GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » Scaled Net Operating Assets

Etropal AD (XBUL:ETR) Scaled Net Operating Assets : 0.72 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Etropal AD Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Etropal AD's operating assets for the quarter that ended in Dec. 2023 was лв18.48 Mil. Etropal AD's operating liabilities for the quarter that ended in Dec. 2023 was лв5.64 Mil. Etropal AD's Total Assets for the quarter that ended in Dec. 2022 was лв17.95 Mil. Therefore, Etropal AD's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.72.


Etropal AD Scaled Net Operating Assets Historical Data

The historical data trend for Etropal AD's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD Scaled Net Operating Assets Chart

Etropal AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.85 1.01 0.80 0.72

Etropal AD Quarterly Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.88 0.79 0.77 0.72

Competitive Comparison of Etropal AD's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Etropal AD's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Etropal AD's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Etropal AD's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Etropal AD's Scaled Net Operating Assets falls into.


;
;

Etropal AD Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Etropal AD's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(18.482-5.636)/17.95
=0.72

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=18.562 - 0.08
=18.482

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.451 - 1.212 - 3.603
=5.636

Etropal AD's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Dec. 2022 )
=(18.482-5.636)/17.95
=0.72

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=18.562 - 0.08
=18.482

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.451 - 1.212 - 3.603
=5.636

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Etropal AD Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Etropal AD's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Etropal AD Business Description

Traded in Other Exchanges
N/A
Address
191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.